- Company Directors - N
- Nash David
Insider Trading History of Nash David
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Nash David since 2012.
The trader's CIK number is 1251968.
At the time of the last reporting, Nash David was the Director of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP).
Also see all insider trading activities at Ani Pharmaceuticals Inc.
Note that in the past
NASH DAVID also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Ani Pharmaceuticals Inc (ANIP) by Nash David
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | ANIP | 1,445 | $99,358 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Humana Inc (HUM) by Nash David
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | HUM | 112 | $9,848 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Endo Pharmaceuticals Holdings Inc (ENDP) by Nash David
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ENDP | 670 | $20,636 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Nash David:
1. Ani Pharmaceuticals Inc (ANIP)
2. Humana Inc (HUM)
3. Endo Pharmaceuticals Holdings Inc (ENDP)
Table 1. Insider trading of Ani Pharmaceuticals Inc (ANIP) by Nash David
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-05-24 | ANIP | Buy | 1,445 | 68.76 | 99,358 |
Table 2. Insider trading of Humana Inc (HUM) by Nash David
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-03-28 | HUM | Buy | 112 | 87.93 | 9,848 |
Table 3. Insider trading of Endo Pharmaceuticals Holdings Inc (ENDP) by Nash David
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-03-05 | ENDP | Buy | 670 | 30.80 | 20,636 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nash David
(Director of Ani Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.